---
title: "Glaukos Q4 2025 earnings preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276015466.md"
description: "Glaukos (GKOS) is set to announce its Q4 earnings on February 16th, post-market. The consensus EPS estimate is -$0.20, reflecting a 50% year-over-year increase, while the revenue estimate stands at $137.03 million, a 29.9% year-over-year rise. Historically, GKOS has met EPS estimates 50% of the time and revenue estimates 100% of the time over the past two years."
datetime: "2026-02-15T22:49:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276015466.md)
  - [en](https://longbridge.com/en/news/276015466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276015466.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276015466.md) | [繁體中文](https://longbridge.com/zh-HK/news/276015466.md)


# Glaukos Q4 2025 earnings preview

Glaukos (GKOS) is scheduled to announce Q4 earnings results on Monday, February 16th, after market close.The consensus EPS Estimate is -$0.20 (+50.0% Y/Y) and the consensus Revenue Estimate is $137.03M (+29.9% Y/Y).Over the last 2 years, GKOS has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time.Over the last 3 ...

### Related Stocks

- [Glaukos Corporation (GKOS.US)](https://longbridge.com/en/quote/GKOS.US.md)

## Related News & Research

- [Glaukos (GKOS) Valuation Check As iDose Sales Momentum Meets Impairment Charge And Upbeat 2026 Outlook](https://longbridge.com/en/news/277346802.md)
- [AI Adoption Raises Operational, Regulatory, and Reputational Risks for Glaukos Corp.](https://longbridge.com/en/news/276708178.md)
- [Glaukos’ 2025 Loss, Impairment and ESOP Shelf Might Change The Case For Investing In GKOS](https://longbridge.com/en/news/277607369.md)
- [11,479 Shares in Glaukos Corporation $GKOS Bought by Y Intercept Hong Kong Ltd](https://longbridge.com/en/news/274505284.md)
- [Glaukos (NYSE:GKOS) Director Sells $1,915,650.00 in Stock](https://longbridge.com/en/news/273781430.md)